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 5 
Abstract 6 
Introduction: Evidence suggests approximately 40% of intramedullary (IM) canals are culture 7 
positive at resection for infected knee arthroplasty. While commonly utilized, no clinical data on 8 
the efficacy of antibiotic-eluding IM dowels exists.  We quantified treatment success with and 9 
without the use of antibiotic-eluding IM dowels in two-stage treatment of periprosthetic knee 10 
infection using static and articulating antibiotic cement spacers. 11 
Methods: 109 consecutive patients who underwent two-stage treatment for periprosthetic knee 12 
infection were reviewed. Treatment failure, defined as repeat resection before reimplantation or 13 
recurrent infection within 6 months of reimplantation, was evaluated based on spacer type and 14 
use of IM dowels, accounting for infection type, and systemic host and local extremity grade.   15 
Results: After exclusions for confounds, articulating spacers without IM dowels were used in 49  16 
(57.7%) cases, articulating spacers with IM dowels in 14 cases (16.5%), and static spacers with 17 
IM dowels in 22  (25.9% ) cases.  Treatment success regardless of infection classification was 18 
85.7%  for articulating spacers with IM dowels, 89.8%  for articulating spacers without IM 19 
dowels, and 68.2%  for static spacers with IM dowels (p = 0.074 ).  In chronically infected poor 20 
hosts with compromised extremities, treatment success remained highest in patients with 21 
articulating spacers with (90.9%) or without (92.9%)  IM dowels compared to static spacers with 22 
IM dowels (68.4%) (p = 0.061).   23 
Conclusion:  Findings suggest that the use of IM dowels did not enhance infection eradication 24 
above and beyond that observed for articulating spacers alone, including in the worst cases 25 
involving chronically infected poor hosts with compromised extremities.  26 
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Introduction 31 
Two-stage treatment of periprosthetic knee infection employs either articulating or static 32 
high dose antibiotic-eluding tibiofemoral cement spacers between resection and reimplantation, 33 
with or without antibiotic-eluding intramedullary (IM) dowels.  Systematic reviews comparing 34 
articulating and static spacers do not address IM dowels but do provide general consensus that 35 
the two spacer types equivalently eradicate infection although articulating designs result in 36 
improved range of motion and function following reimplantation. [1-3]  However, one review 37 
observed a significantly lower reinfection rate with articulating spacers, [4] and all four reviews 38 
commented on the absence of comprehensive and high quality comparative studies.  After review 39 
and consideration of the available evidence, the 2018 International Consensus Meeting on 40 
Periprosthetic Joint Infection recommended the use of articulating spacers unless static spacers 41 
are indicated by severe bone loss, ligament insufficiency, or soft tissue compromise; [5] 42 
however, the International Consensus group did not comment on the use of IM dowels to 43 
enhance treatment and facilitate the eradication of infection. 44 
Although studies on spacer type and efficacy are limited, data on the need for and 45 
efficacy of antibiotic-eluding IM dowels are non-existent.  High-dose antibiotic IM dowels are 46 
not uncommonly used in practice to enhance antibiotic delivery specifically into the IM tibial 47 
and femoral canals.  Hanssen and Spangehl [6] recommended antibiotic cement IM dowels based 48 
on the fact that “In roughly 1/3 of infected knee replacements without stems there is an extension 49 
of the infectious process into the medullary canals of the femur or tibia.”  Their recommendation 50 
was based on the 1997 study by McPherson and colleagues [7] who reported that 39% of 71 51 
positive growth cultures taken at resection were from medullary canal specimens. Yet, despite 52 
this single study over two decades ago supporting the rationale for antibiotic cement IM dowels 53 
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being commonly used in practice, studies on the efficacy of and justifying the use of antibiotic-54 
eluding IM dowels do not currently exist.  The purpose of this study was to quantify treatment 55 
success rates with and without the use of antibiotic-eluding IM dowels in two-stage treatment of 56 
periprosthetic knee infection using both high-dose antibiotic cement static and articulating 57 
spacers. 58 
Methods 59 
Study Sample 60 
One-hundred and nine consecutive patients who underwent two-stage treatment for 61 
periprosthetic knee infection by one of four academic surgeons between 08/30/2010 and 62 
07/20/2017 were retrospectively reviewed with Institutional Review Board approval.  Surgeries 63 
were performed with the same perioperative protocols at one of two tertiary referral centers for 64 
patients with more severe medical comorbidities. Twenty-four cases were excluded because they 65 
involved extensor mechanism repair (9), resection of an existing antibiotic spacer (6), skin 66 
reconstruction (4), resection of a distal femoral replacement (3), and resection of 11.5 cm of 67 
necrotic distal femoral bone (1).  One additional single case in which a static spacer without 68 
dowels was used also was excluded. 69 
Surgical Procedures 70 
During initial stage resection, procedures were typically performed under tourniquet until 71 
exposure and debridement was completed.  Then prior to cementation of the antibiotic cement 72 
spacer, the tourniquet was let down to obtain hemostasis and also to prevent excessive cement 73 
interdigitation to facilitate spacer removal at second stage reimplantation.  Procedures were 74 
typically performed through an anterior longitudinal incision, ellipsing and excising any tenuous 75 
regions of the previous incision to facilitate wound approximation and postoperative healing.  A 76 
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median parapatellar arthrotomy was performed in all cases and if extensile exposure was needed 77 
a quadriceps snip was performed.  Five cultures were routinely obtained from within the knee 78 
joint and sent to microbiology for analysis.  Meticulous and careful exposure was performed 79 
with synovial tissue excision and debridement of the suprapatellar pouch, and medial and lateral 80 
gutters, and the retropatellar fat pad/scar tissue was excised to eradicate the infection and 81 
facilitate exposure.   82 
Femoral and tibial implants were carefully removed with a combination of reciprocating 83 
saws and osteotomes. All residual cement was removed with a combination of osteotomes and 84 
rongeours, taking care to preserve as much bone as possible. Particular attention was paid to any 85 
cement in previous drill or peg holes to ensure removal and a thorough debridement. Femoral 86 
and tibial intramedullary canals were opened and debrided in all cases using reverse curettes, 87 
scrapers, and flexible reamers.  A careful assessment of femoral and tibial bone loss was 88 
performed to determine whether an articulating spacer was feasible, and to determine the future 89 
reimplantation and reconstruction strategy. With the knee in flexion, the posterior capsule and 90 
infected synovium were excised and debrided carefully to avoid damaging posterior 91 
neurovascular structures.  The polyethylene patella component was removed in all cases and all 92 
visible cement was removed from patellar, femoral, and tibial bone. The knee joint was then 93 
irrigated with 6 liters of bacitracin-containing pulsed lavage.  The tourniquet was deflated 94 
and hemostasis was obtained.  Particular attention was paid to irrigating all bone surfaces and 95 
periarticular tissues thoroughly, as well as into the femoral and tibial canals. Periarticular tissues 96 
were soaked in a dilute betadine solution of 0.35% for 3 minutes, followed by 3 more liters of 97 
normal saline pulsed irrigation.   98 
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An articulating or static spacer was implanted as appropriate.  In cases where adequate 99 
bone stock was available and an articulating spacer was indicated (n = 63), one of three different 100 
types were used: 13  (20.6% ) pre-fabricated spacers (REMEDY® Knee Spacer, OsteoRemedies, 101 
Memphis, TN), 23  (36.5% ) molded antibiotic tibial and femoral spacers (Zimmer Biomet, 102 
Warsaw, IN), and 27  (42.9% ) molded cement femoral components and all-poly tibial inserts 103 
implanted with high-dose antibiotic cement (Depuy Synthes, Warsaw, IN).  Indications for 104 
static spacers were at the discretion of the surgeon and included substantial bone loss and 105 
collateral ligament integrity. In cases where a static spacer was deemed appropriate (n = 22), 106 
high-dose antibiotic-laden cement was molded to the distal femur and proximal tibia. IM dowels 107 
were used with all static spacers and, depending on surgeon preference, were formed around a 108 
central reinforcing Steinmann pin (Key Surgical, Minneapolis, MN) or nail (Fixation Recon 109 
Nail, Zimmer Biomet, Warsaw, IN) or constructed without a central metal pin utilizing a cement 110 
gun nozzle (Stryker, Mahwah, NJ) lubricated with normal saline to facilitate cement removal 111 
once cured.  Spacer and dowel constructs are shown in Figure 1.  The distribution of femoral and 112 
tibial IM dowels is presented in Table 1 based on spacer type and method of dowel construction.   113 
Spacers and dowels utilized high-dose antibiotic cement (Biomet Cobalt; Stryker Simplex 114 
P, Zimmer Palacos) and dosing appropriate for the cement type.  For Cobalt and Palacos cement, 115 
2 grams of vancomycin and 0-2 grams tobramycin was used, and for Simplex P cement, 3-4 116 
grams of vancomycin and 3.6 grams tobramycin were utilized.  In Simplex P, one cubic 117 
centimeter of methylene blue per cement batch was added to provide color to facilitate 118 
visualization upon removal at reimplantation. In indicated cases of multi-organism and 119 
recalcitrant infections, an antifungal (50 micrograms Amphotericin B) was added to the cement.  120 
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A hemovac drain was used in all cases and closure was performed in standard 121 
fashion.  Patients were discharged with 6 weeks of intravenous, primarily single antibiotic 122 
therapy (ampicillin, cefazolin, cefepime, ceftaroline, ceftriaxone, daptomycin, vancomycin, or 123 
zosyn).  If preoperative or intraoperative cultures failed to grow an organism (“culture-124 
negative”), patients were typically treated with dual-antibiotic broad-spectrum intravenous 125 
therapy for the 6-week interval.  Upon completion of intravenous antibiotics, all patients 126 
underwent a two-week antibiotic-free interval with serologic testing to include erythrocyte-127 
sedimentation rates (ESR) and C-reactive protein (CRP) counts.  If either lab was elevated or 128 
clinical suspicion was high, the knee was aspirated for analysis of cell counts, differentials, and 129 
cultures prior to reimplantation.   130 
Measures 131 
The electronic medical record was used to compile study data: patient sex, age, body 132 
mass index (BMI) in kg/m2, intraoperative culture results (infectious organisms), McPherson et 133 
al./University of Southern California Classification for Prosthetic Joint Infection [8], whether 134 
traditional Musculoskeletal Infection Society (MSIS) criteria [9] were met, spacer type, whether 135 
or not IM dowels were used and where (femur only, tibia only, or both), stage one surgical 136 
procedure operating time in minutes, and time between resection and reimplantation in months.  137 
McPherson et al.’s classification system for PJI assesses each patient according to three 138 
categories—infection type, systemic host grade (medical/immune status), and local extremity 139 
grade—resulting in a single infection classification (e.g., I-A-1; Table 2).  Per McPherson et 140 
al.’s classification system, infections in chronically infected poor hosts are designated as 141 
IIIB and IIIC.  Treatment success was defined as no repeat resection before reimplantation and 142 
no recurrent infection within 6 months of reimplantation.  143 
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Data Analysis 144 
Minitab 18 (State College, PA) was used for statistical analysis.  Analysis of variance (F) 145 
was used to compare mean values in three groups (articulating spacers with IM dowels, 146 
articulating spacer without IM dowels, and static spacers with IM dowels).  Pearson’s Chi-147 
Square (X2) test was used to test independence among categorical variables.  Post hoc z tests 148 
with Fishers Exact test p value were used to compare specific group proportions.  A significance 149 
level of ≤ 0.05 was used for all statistical analyses. 150 
Results 151 
 Slightly more females (44, 51.8%) than males (41, 48.2%) comprised the final sample of 152 
85 consecutive two-stage treatment cases.  Average age and BMI were 66 (SD 9.0) years and 36 153 
(SD 9.0) kg/m2, respectively.  Ninety-nine percent (84/85) of sample cases met traditional MSIS 154 
criteria for PJI.  The patient who did not fit traditional MSIS criteria had elevated ESR, CRP 155 
counts, and intraoperative white cell counts but the values did not meet traditional MSIS 156 
thresholds.   157 
Articulating spacers without IM dowels were used in 49 (57.7%) cases, articulating 158 
spacers with IM dowels were used in 14 cases (16.5%), and static spacers with IM dowels were 159 
used in 22 (25.9%) cases.  Overall treatment success rates regardless of McPherson infection 160 
classification are shown for the three groups in Figure 2 (X2 = 5.2, p = 0.074).  Paired 161 
comparisons indicated no statistical difference in treatment success between articulating spacers 162 
with and without IM dowels (85.7% vs. 89.8%, z = 0.40, p = 0.646), and between articulating 163 
spacers with dowels and static spacers with dowels (85.7% vs. 68.2%, z = 1.29, p = 0.432) with 164 
the numbers available.   A significantly greater treatment success rate was observed for 165 
articulating spacers without IM dowels compared to static spacers with IM dowels (89.8% vs. 166 
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68.2%, z = 2.00, p = 0.039).  Treatment success rates based on the location of dowels in the 167 
femur only (66.7%, 2/3), the tibia only (0%, 0/1), or both the femur and the tibia (78.1%, 25/32) 168 
could not be tested due to small numbers in the groups. 169 
 PJI classification is provided in Table 3 based on spacer type and the use of IM dowels 170 
with gray shading demarcating classifications associated with chronically infected poor hosts 171 
with compromised extremities (III B/C 2/3).  Significantly more patients with static spacers and 172 
IM dowels (19/22, 86.4%), followed by patients with articulating spacers and IM dowels (11/14, 173 
78.6%), and articulating spacers without IM dowels (28/49, 57.1%) were chronically infected 174 
poor hosts with compromised extremities (X2 = 6.807, p = 0.033).  As shown in Figure 2, 175 
however, among chronically infected poor hosts with compromised extremities, treatment 176 
success rates remained the highest in patients with articulating spacers with  (90.9% ) and 177 
without IM dowels (92.9% ) compared to static spacers with IM dowels (68.4%  (X2 = 5.582  , p 178 
= 0.061 ).  Treatment success rates in these patients with articulating spacers with and without 179 
IM dowels (90.9% vs. 92.9%; z = 0.20, p = 1.000) did not differ in paired comparisons. There 180 
was no statistically significant difference in success rates between articulating spacers with 181 
dowels and static spacers with dowels with the numbers available (90.9% vs. 68.4%, z = 1.64, p 182 
= 0.215).  Treatment success rates were significantly higher in comparisons of articulating 183 
spacers without dowels and static spacers with dowels (92.9% vs. 68.4%, z = 2.08, p = 0.047).   184 
Patient sex, age, BMI, infectious organisms, stage one operating time, time between 185 
resection and reimplantation, chronic antibiotic suppression, and most serious infection-related 186 
procedure prior to the index resection are provided in Table 4 for successfully treated cases 187 
based on spacer type and the use of IM dowels.  Treatment success in the three spacer/IM dowel 188 
groups did not vary based on sex (p = 0.824), age (p = 0.456), or BMI (p = 0.111).  There were 189 
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no differences in the proportion of each group with antibiotic resistant organisms (p = 190 
0.089).  As would be expected, stage one operating time significantly increased commensurate 191 
with the amount of time required for the construction of spacers and dowels (p = 0.002).  The 192 
time between resection and reimplantation did not differ based on spacer and dowel constructs (p 193 
= 0.822). The proportion of patients on chronic antibiotic suppression following 194 
reimplantation did not statistically differ in the three spacer/IM dowel groups (p = 0.399).   195 
Significantly fewer patients with static spacers and IM dowels (26.6%), followed by 196 
patients with articulating spacers without dowels (59.1%), and those with articulating 197 
spacers with dowels (75.0%) had no infection-related procedures prior to the index 198 
resection (X2 = 7.10, p = 0.029). 199 
Discussion 200 
The use of evidence-based maximally effective treatment methods for PJI is second in 201 
urgency and importance only to the prevention and eradication of PJI itself.  In the best case 202 
scenario, infected total and revision knees result in a devastating financial burden to patients and 203 
the healthcare system and exact a heavy emotional and functional toll on patients and their 204 
families.  In the worst case scenario, devastating disability may ensue as a result of fusion or 205 
amputation.  PJI is the antithesis of the functional independence and full, healthy lifestyle total 206 
joint arthroplasty surgeons strive to achieve for patients and therefore, appropriate and effective 207 
treatment strategies must be optimized to minimize the burden and maximize patient outcomes.  208 
The efficacy of articulating and static spacers in two-stage treatment for periprosthetic 209 
knee infection has been studied [1-4] but there is a lack of data on the efficacy of IM dowels, a 210 
potentially important tool to facilitate treatment and eradication of PJI of the knee via focused 211 
delivery of antibiotics into the IM canals of the femur and tibia.  Our examination of the 212 
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effectiveness of IM dowels in a demographically typical resection sample supports existing 213 
studies demonstrating greater treatment success with articulating spacers compared to static 214 
spacers, although existing studies have not assessed whether IM dowels provide additional 215 
efficacy.    As shown in Figure 2, our observations suggest that antibiotic impregnated IM 216 
dowels do not improve upon the superior treatment efficacy provided by articulating compared 217 
to static spacers.  Two stage treatment success rates were high when articulating spacers were 218 
used whether or not IM dowels were used, especially in the presence of chronically infected poor 219 
hosts with compromised extremities. 220 
This study does have limitations.  First it is retrospective in design and lacks the scientific 221 
rigor of randomization with respect to spacer type or presence of IM dowels.  Second, due to the 222 
variability and complicated nature of PJI after TKA, we had to account for two variables: 223 
articulating versus static spacers with or without IM dowels.  This effected the ability to isolate 224 
the variable of primary interest, the presence of high dose antibiotic IM dowels.  Finally, there is 225 
a treatment bias that is evident with the surgeon decision to use a specific spacer type, in that 226 
significantly more patients with static spacers and IM dowels (86.4% ), followed by patients with 227 
articulating spacers and IM dowels (78.6%), and articulating spacers without IM dowels (57.1%) 228 
were chronically infected poor hosts with compromised extremities (p = 0.033 ).  Further, 229 
patients with static spacers had on average a greater number of infection related surgical 230 
procedures than patients with articulating spacers (p = 0.029), suggesting an increased level 231 
of complexity and potential worse prognosis for infection eradication in those patients with 232 
prior infection procedures. Despite these limitations, this study does have noteworthy 233 
strengths.  First, this study includes a relatively large sample size, which is difficult to achieve in 234 
this particular topic and treatment modality.  Second, the variability of spacer type and presence 235 
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of IM dowels was accounted for statistically to isolate each variable and correlation with 236 
treatment success. 237 
Our study provides value in so far as, to the best of our knowledge, it is the only 238 
investigation to date quantifying the effectiveness of IM dowels in the treatment of periprosthetic 239 
knee infection.  Further, the commonly quoted incidence of approximately 40% of 240 
intramedullary canals having positive cultures at the time of resection currently lacks clinical 241 
validation and the findings reported here provide corroboration via clinical outcome data.  We 242 
encourage additional research to verify our observation that the use of IM dowels did not 243 
enhance infection eradication above and beyond that observed for articulating spacers alone, 244 
including in the worst cases involving chronically infected poor hosts with compromised 245 
extremities. 246 
247 
248 
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Figure Legends 
Figure 1. Radiographic images of spacer and dowel constructs.  (A) Pre-fabricated articulating 
spacer with Steinmann pin IM dowels, (B) Molded antibiotic tibial and femoral spacers without 
IM dowels, (C) Molded cement femoral components and all-poly tibial inserts implanted with 
high-dose antibiotic cement without IM dowels, and (D) Static spacer with cement gun nozzle 
IM Dowels. 
Figure 2.  Overall treatment success rates (left) and success rates in chronically infected poor 
hosts (right) based on spacer type and the use of IM dowels. 
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Table 2: McPherson et al.’s Classification System for PJI 
Infection Type 
I. Early postoperative (≤ 4 weeks postoperative) 
II. Acute hematogenous infection (≤ 4 weeks duration) 
III. Late chronic infection (> 4 weeks duration) 
Systemic Host Grade (Medical/Immune Status) 
A. Uncompromised (no compromising factors) 
B. Compromised (≤ compromising factors) 
C. Significant compromise (> 2 compromising factors) 
Local Extremity Grade 
1. Uncompromised (no compromising factors) 
2. Compromised (≤ compromising factors) 
3. Significant compromise (> 2 compromising factors) 
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Table 1: Distribution of Femoral and Tibial Dowels Based on Spacer Type and Method of 
Dowel Construction 
Dowel Type 
Steinmann 
Pin 
Reconstruction 
Nail 
Hardened 
Cement Total 
Static Spacers With Dowels 
 Femur & Tibia 13 3 6 22 
Articulating Spacer with Dowels 
 Femur & Tibia 9 0 1 10 
 Femur Only 0 0 3 3 
 Tibia Only 1 0 0 1 
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Table 3: Prosthetic Joint Infection Classification Based on Spacer Type and the Use of IM Dowels 
Static spacer with IM 
dowels 
Articulating spacer with 
IM dowels 
Articulating spacer 
without IM dowels 
N 22 14 49 
Stage 
I-A-1 to I-C-3 0.0 14.3 24.5 
II-A-1 to II-C-3 4.6 7.1 18.4 
III-A-1 to III-A-3 4.6 0.0 0.0 
III-B-1 0.0 0.0 0.0 
III-B-2 13.6 14.3 24.5 
III-B-3 22.7 7.1 10.2 
III-C-1 4.6 0.0 0.0 
III-C-2 13.6 50.0 10.2 
III-C-3 36.4 7.1 12.2 
Gray shading demarcates stages associated with chronically infected poor hosts with compromised 
extremities 
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Table 4: Characteristics of Successfully Treated Cases Based on Spacer Type and the Use of IM Dowels 
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Statistic p 
N 15 12 44 
% Female 46.7 58.3 50.0 X2 = 0.386 0.824 
Mean (SD) Age in Years 64.7 (9.6) 69.0 (8.8) 65.4 (9.0) F = 0.79 0.456 
Mean (SD) BMI in kg/m2 39.5 (9.6) 37.3 (6.3) 34.1 (9.3) F = 2.28 0.111 
% Infectious Organism 
 NGTD 33.2 8.3 36.4 * *
 CoNS 13.3 41.7 15.9 
 MRSA 6.7 16.8 0.0 
 MSSA 6.7 8.3 25.0 
 Streptococcus 6.7 8.3 9.1 
 Other 6.7 8.3 6.8 
 Polymicrobial excluding Resistant Organisms 20.0 0.0 4.5 
 Polymicrobial including Resistant Organisms 6.7 8.3 2.3 
% Antibiotic Resistant Organism = Yes 20.0 27.3 3.6 X2 = 4.832 0.089 
Mean (SD) Stage One Operating Time in Minutes 137.4 (23.8) 
117.8 
(33.9) 
106.6 
(26.7) F = 7.14 0.002 
Mean (SD) Time Between Resection and 
Reimplantation in Months 2.8 (1.4) 2.7 (1.0) 2.6 (0.8) F = 0.20 0.822 
% Chronic Antibiotic Suppression Following 
Reimplantation 21.4 20.0 8.6 X
2 
= 1.837 0.399 
% Most Serious Infection-Related Procedures Prior 
to Index Resection 
 Treatment of TKA Arthrotomy Wound 6.7 0.0 4.6 * *
 Arthroscopic I&D 0.0 0.0 4.6 
 Open I&D without Liner Exchange 6.7 8.3 15.9 
 Open I&D with Liner Exchange 6.7 0.0 9.0 
 Resection and Reimplantation at OSH 53.3 16.7 6.8 
 None 26.6 75.0 59.1 
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*Chi-Square invalid due to low cell counts
NGTD = no growth to date 
CoNS = coagulase-negative staphylococci 
MRSA = Methicillin-resistant Staphylococcus aureus 
MSSA = Methicillin-sensitive Staphylococcus aureus 
Other = Corynebacterium, Enterococcus, Pasturella multocida, Pseudomonas aeruginosa 
Polymicrobial = Combinations of CoNS, Corynebacterium species, Enterococcus, Escherichia coli, Group B 
streptococcus, Group C streptococcus, Kebsiella oxytoca, MRSA, MSSA, Peptostreptococcus, Providencia, 
Prevotella anaerobic gram-negative rods, Pseudomonas, Staphylococcus aureus, Staphylococcus lugdunensis, 
Vancomycin-resistant Enterococcus 
I&D = irrigation and debridement 
OSH = outside hospital 
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